Search

everythinglearnresearchcommunity

for

Search:↓

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

A20 protein is crucial for normal skin and hair development.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Activating TLR3 boosts autophagy gene expression in skin cells.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

MSC-CM cream speeds up burn wound healing better than the control treatment.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Nrf2 helps protect skin from damage but too much can cause skin problems.

The EDA pathway plays a key role in bone development by interacting with other signaling pathways.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Trichosanthes kirilowii extract helps wounds heal faster.

Increasing EGR1 levels makes hair root cells grow faster.

EGFR helps protect hair follicles from damage and scarring.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Dermal EZH2 controls skin cell growth and differentiation in mice.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.

CXCR2 in skin cells promotes tumor growth.

Epimorphin helps shape and develop epithelial cells, like those in hair follicles.

Androgen receptors help prostate cancer cells grow and resist drugs.